The overall goal of the University of Chicago Comprehensive Cancer Center (UCCCC) is to improve the prevention, detection, and treatment of cancer through our basic, clinical, translational, and population research activities. Therefore, the effective procurement, storage, use, and analysis of human biospecimens are of critical importance. Furthermore, the maintenance and expansion of these state-of-the-art biospecimen facilities is vital to the future success of our cancer programs. The mission of the Human Tissue Resource Center (HTRC) is to ensure the effective procurement, storage, distribution, utilization, and downstream analysis of human biospecimens. The Facility occupies ~4,000 sq ft of space within the Pathology Department and functions as an integrated unit. Therefore, duplication of personnel, equipment, and information systems is avoided, and coordination of activities is assured. The HTRC is now comprised of four integrated Subcores: Biospecimen Bank (BSB), Laser Capture Microdissection (LCM), Digital Pathology (DP), and Histology Services (HS). Currently, the HTRC provides services for the collection of clinically-annotated human tissues, as well as blood, serum, plasma, and saliva for cancer-related research. In addition, the Facility provides collaborative support and services for histopathology, laser capture microdissection, tissue microarray (TMA) fabrication and quantitative image analysis. By doing so, the HTRC provides cancer investigators with a centralized infrastructure to optimize the efficiency and costs related to research involving human biospecimens.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014599-38
Application #
8486643
Study Section
Subcommittee G - Education (NCI)
Project Start
2013-04-01
Project End
2018-03-31
Budget Start
2013-04-23
Budget End
2014-03-31
Support Year
38
Fiscal Year
2013
Total Cost
$223,990
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Johnson, Marianna B; Hoffmann, Joscelyn N; You, Hannah M et al. (2018) Psychosocial Stress Exposure Disrupts Mammary Gland Development. J Mammary Gland Biol Neoplasia 23:59-73
Sweis, Randy F; Zha, Yuanyuan; Pass, Lomax et al. (2018) Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer. J Immunother Cancer 6:24
Kathayat, Rahul S; Cao, Yang; Elvira, Pablo D et al. (2018) Active and dynamic mitochondrial S-depalmitoylation revealed by targeted fluorescent probes. Nat Commun 9:334
Liu, Jun; Eckert, Mark A; Harada, Bryan T et al. (2018) m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol 20:1074-1083
Bhanvadia, Raj R; VanOpstall, Calvin; Brechka, Hannah et al. (2018) MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease. Clin Cancer Res 24:3668-3680
Wood, Kevin; Byron, Elizabeth; Janisch, Linda et al. (2018) Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms. Am J Clin Oncol 41:963-966
Sample, Ashley; Zhao, Baozhong; Wu, Chunli et al. (2018) The Autophagy Receptor Adaptor p62 is Up-regulated by UVA Radiation in Melanocytes and in Melanoma Cells. Photochem Photobiol 94:432-437
Hrusch, C L; Manns, S T; Bryazka, D et al. (2018) ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s. Mucosal Immunol 11:61-70
Hope, C Matthew; Webber, Jemma L; Tokamov, Sherzod A et al. (2018) Tuned polymerization of the transcription factor Yan limits off-DNA sequestration to confer context-specific repression. Elife 7:
Wong, Gabrielle S; Zhou, Jin; Liu, Jie Bin et al. (2018) Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition. Nat Med 24:968-977

Showing the most recent 10 out of 668 publications